CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement Post author:GHIAA Admin Post published:May 24, 2022 Post category: Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement
CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement Post author:GHIAA Admin Post published:May 24, 2022 Post category: Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement
CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement Post author:GHIAA Admin Post published:May 23, 2022 Post category: Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement
Novavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement Post author:GHIAA Admin Post published:April 20, 2022 Post category: Continue ReadingNovavax – Serum Institute of India, COVID-19 Vaccine Supply and License Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:January 3, 2022 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:January 3, 2022 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 27, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 27, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 27, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement